vimarsana.com

Latest Breaking News On - உகந்த தேசிய பணியகம் ஆஃப் புள்ளிவிவரங்கள் - Page 1 : vimarsana.com

Registration for covid relief cash starts today

Registration for covid relief cash starts today
kfm.co.ug - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kfm.co.ug Daily Mail and Mail on Sunday newspapers.

Covid vaccine manufacturers turning focus on children

Covid vaccine manufacturers turning focus on children Tuesday April 06 2021 A member of the medical staff prepares a dose of the Covid-19 AstraZeneca/Oxford vaccine at a refugees and migrants camp in Obrenovac, Serbia, on March 29, 2021. PHOTO/AFP Summary International experts, however, warn that delaying or not vaccinating children against Covid-19 could create a dangerous reservoir for the coronavirus.  Advertisement Manufacturers of Covid-19 vaccines in America and Britain have turned their focus to testing the serum on children to make sure the vaccines are safe for the youngsters. There is still no Covid-19 vaccine approved by notable health agencies and regulators such as the World Health Organisation (WHO) or American Food and Drug Authority (FDA) for children aged 15 years and below. 

Maize ban should help us rethink agricultural extension services

Daily Monitor Tuesday March 16 2021 On March 5, the Kenyan Government issued a ban on the importation of maize from Uganda. The decision, according to the head of Kenyan Agriculture and Food Authority, stemmed from their findings on the safety of food imports to Kenya that revealed maize from Uganda and Tanzania contains substances that cause cancer. This decision has attracted an unprecedented response from some Ugandan legislators, who proposed a ban on agricultural imports from Kenya in retaliation. Whereas the need to protect Ugandan traders involved in maize export is understandable, our legislators should become more proactive to deal with the root cause of the problem and save us from future troubles.  

Why Uganda is opting for AstraZeneca

Daily Monitor Wednesday February 17 2021 A vial containing the Covid-19 vaccine by AstraZeneca at the Robert Bosch Hospital in Stuttgart, Germany. PHOTO AFP Advertisement The AstraZeneca vaccine being purchased by government has 63 per cent efficacy in preventing Covid-19 illness, the World Health Organisation (WHO) revealed on Monday. “The AstraZeneca/Oxford product is a viral vectored vaccine. AstraZeneca has been found to have 63.09 per cent efficacy and is suitable for low and middle-income countries due to easy storage requirements,” WHO said in a statement, adding the vaccine has been listed for emergency use. This efficacy is, however, 30 per cent below the Pfizer and Moderna vaccines, which are being used in other countries, including Rwanda.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.